Allied Market Research

2024

Companion Animal Pharmaceuticals Market

Companion Animal Pharmaceuticals Market Size, Share, Competitive Landscape and Trend Analysis Report by Companion Animals, by Drug Class and by Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

A companion animal is a non-assistive animal used for psychological support, amusement, company, extrovert display, and several other functions that a human needs to share with animals. Dogs, cats, horses, birds, mice, and guinea pigs are some of the animals that can be considered as companion animals. Numerous studies have shown that positive health benefits, such as lowered blood pressure, decreased anxiety, decreased cardiac arrhythmias, greater psychological stability, and improved well-being are associated with owning a companion animal. Furthermore, companion animal pharmaceuticals are used to sedate, treat, and improve their health and performance. It is essential to take care of these animals and provide essential health services to them.

 

COVID-19 scenario analysis

The coronavirus pandemic is having a huge impact on businesses and has already caused an unprecedented collapse of economic activities. The COVID-19 impact is straining the healthcare systems globally and has disrupted the supply chain for the companion animal pharmaceuticals market, temporarily leading to a decline in the demand for these products. The rapidly increasing demand for healthcare facilities and healthcare workers may leave only a few healthcare systems to meet the increasing demand during the pandemic situation.

Although there has been no evidence or confirmation that animals can spread COVID-19 to humans, the myth that animals can spread the virus to humans has increased the number of abandoned pets. Furthermore, COVID-19 has weakened the supply chain and has created shortage of animal health products such as nutritional feed as well as vaccines globally. The animal health industry has been largely impacted, as many manufacturers in animal health industry are left with a significantly reduced workforce. Moreover, implementation of stringent government policies such as restrictions of import of raw materials from China is expected to hamper the animal health market.

Healthcare facilities are stocking up animal-related health products, considering the high demand. This is expected to further create financial strain on the market due to procurement inefficiencies and wasted speeding. Due to the pandemic situation, many hospitals and veterinary clinics are overstocking the products.

Top impacting factors: market scenario analysis, trends, drivers, and impact analysis

With surge in companion animal population and increase in animal health expenditure, many players from international markets are focusing on investing in this particular market. Moreover rise in prevalence of zoonotic diseases such as rabies, salmonellosis, plague, brucellosis, and Lyme are major concern among animal keepers, which is driving the growth of the companion animal pharmaceuticals market. The market is being restrained by lack of awareness about animal healthcare and rise in pet care cost.

Key benefits of the report

  • This study presents the analytical depiction of the global companion animal pharmaceuticals market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions answered in the companion animal pharmaceuticals market report

  • Which are the leading players active in the companion animal pharmaceuticals market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What are the projections for the future that would help in taking further strategic steps?

Companion Animal Pharmaceuticals Market Report Highlights

Aspects Details
icon_5
By Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others
icon_6
By Drug Class
  • Antibiotics
  • Anti-inflammatory
  • Heart Worm Drugs
  • Parasiticides
  • Nutritional Drugs
  • Behavioral Drugs
  • Vaccines
  • Others
icon_7
By Distribution Channel
  • Veterinary Pharmacies
  • E-commerce
  • Retail Pharmacies
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

Agrolabo S.p.A., Eli Lily, Merck & Co., Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Zoetis, Virbac, Ceva Santé Animale, Indian Immunologicals Ltd., IDEXX Laboratories, Inc., Vetoquinol S.A.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Companion Animal Pharmaceuticals Market

Global Opportunity Analysis and Industry Forecast, 2023-2032